NPCE — Neuropace Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Neuropace, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	38.1	116	77.4	66.5	52.8
Net Total Accounts Receivable
Net Total Receivables	8.39	7.09	7.48	12.3	12.9
Total Inventory
Prepaid Expenses
Total Current Assets	54.6	133	97.7	92.7	81.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.515	0.603	15.9	14.4	12.9
Other Long Term Assets
Total Assets	56	134	114	108	94.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.6	9.3	11	16.2	15.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	62.4	60.1	79.3	87	86.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-6.41	73.5	34.8	20.7	8.01
Total Liabilities & Shareholders' Equity	56	134	114	108	94.6
Total Common Shares Outstanding